Global Diabetes Therapy and Drug Delivery Market Research Report 2023

Diabetes Therapy and Drug Delivery Market

According to new survey, global Diabetes Therapy and Drug Delivery market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Diabetes Therapy and Drug Delivery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Diabetes Therapy and Drug Delivery Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Inhalable Insulin

1.2.3 Oral Insulin

1.2.4 Insulin Patches

1.2.5 CGM Systems

1.2.6 Artificial Pancreas

1.3 Market by Application

1.3.1 Global Diabetes Therapy and Drug Delivery Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Diagnostic/Clinics

1.3.3 ICUs

1.3.4 Home Healthcare

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Diabetes Therapy and Drug Delivery Market Perspective (2018-2029)

2.2 Diabetes Therapy and Drug Delivery Growth Trends by Region

2.2.1 Global Diabetes Therapy and Drug Delivery Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Diabetes Therapy and Drug Delivery Historic Market Size by Region (2018-2023)

2.2.3 Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2024-2029)

2.3 Diabetes Therapy and Drug Delivery Market Dynamics

2.3.1 Diabetes Therapy and Drug Delivery Industry Trends

2.3.2 Diabetes Therapy and Drug Delivery Market Drivers

2.3.3 Diabetes Therapy and Drug Delivery Market Challenges

2.3.4 Diabetes Therapy and Drug Delivery Market Restraints

3.1 Global Top Diabetes Therapy and Drug Delivery Players by Revenue

3.1.1 Global Top Diabetes Therapy and Drug Delivery Players by Revenue (2018-2023)

3.1.2 Global Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2018-2023)

3.2 Global Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Diabetes Therapy and Drug Delivery Revenue

3.4 Global Diabetes Therapy and Drug Delivery Market Concentration Ratio

3.4.1 Global Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diabetes Therapy and Drug Delivery Revenue in 2022

3.5 Diabetes Therapy and Drug Delivery Key Players Head office and Area Served

3.6 Key Players Diabetes Therapy and Drug Delivery Product Solution and Service

3.7 Date of Enter into Diabetes Therapy and Drug Delivery Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Diabetes Therapy and Drug Delivery Historic Market Size by Type (2018-2023)

4.2 Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2024-2029)

5.1 Global Diabetes Therapy and Drug Delivery Historic Market Size by Application (2018-2023)

5.2 Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2024-2029)

6.1 North America Diabetes Therapy and Drug Delivery Market Size (2018-2029)

6.2 North America Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Diabetes Therapy and Drug Delivery Market Size by Country (2018-2023)

6.4 North America Diabetes Therapy and Drug Delivery Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Diabetes Therapy and Drug Delivery Market Size (2018-2029)

7.2 Europe Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Diabetes Therapy and Drug Delivery Market Size by Country (2018-2023)

7.4 Europe Diabetes Therapy and Drug Delivery Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size (2018-2029)

8.2 Asia-Pacific Diabetes Therapy and Drug Delivery Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region (2018-2023)

8.4 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Diabetes Therapy and Drug Delivery Market Size (2018-2029)

9.2 Latin America Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Diabetes Therapy and Drug Delivery Market Size by Country (2018-2023)

9.4 Latin America Diabetes Therapy and Drug Delivery Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size (2018-2029)

10.2 Middle East & Africa Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country (2018-2023)

10.4 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Detail

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Diabetes Therapy and Drug Delivery Introduction

11.1.4 Abbott Laboratories Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.1.5 Abbott Laboratories Recent Development

11.2 Medtronic

11.2.1 Medtronic Company Detail

11.2.2 Medtronic Business Overview

11.2.3 Medtronic Diabetes Therapy and Drug Delivery Introduction

11.2.4 Medtronic Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.2.5 Medtronic Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Detail

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Diabetes Therapy and Drug Delivery Introduction

11.3.4 Sanofi Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.3.5 Sanofi Recent Development

11.4 Novo Nordisk

11.4.1 Novo Nordisk Company Detail

11.4.2 Novo Nordisk Business Overview

11.4.3 Novo Nordisk Diabetes Therapy and Drug Delivery Introduction

11.4.4 Novo Nordisk Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.4.5 Novo Nordisk Recent Development

11.5 MannKind

11.5.1 MannKind Company Detail

11.5.2 MannKind Business Overview

11.5.3 MannKind Diabetes Therapy and Drug Delivery Introduction

11.5.4 MannKind Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.5.5 MannKind Recent Development

11.6 Enteris BioPharma

11.6.1 Enteris BioPharma Company Detail

11.6.2 Enteris BioPharma Business Overview

11.6.3 Enteris BioPharma Diabetes Therapy and Drug Delivery Introduction

11.6.4 Enteris BioPharma Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.6.5 Enteris BioPharma Recent Development

11.7 Dexcom

11.7.1 Dexcom Company Detail

11.7.2 Dexcom Business Overview

11.7.3 Dexcom Diabetes Therapy and Drug Delivery Introduction

11.7.4 Dexcom Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.7.5 Dexcom Recent Development

11.8 Senseonics Holding

11.8.1 Senseonics Holding Company Detail

11.8.2 Senseonics Holding Business Overview

11.8.3 Senseonics Holding Diabetes Therapy and Drug Delivery Introduction

11.8.4 Senseonics Holding Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.8.5 Senseonics Holding Recent Development

11.9 Medtech

11.9.1 Medtech Company Detail

11.9.2 Medtech Business Overview

11.9.3 Medtech Diabetes Therapy and Drug Delivery Introduction

11.9.4 Medtech Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.9.5 Medtech Recent Development

11.10 Johnson & Johnson

11.10.1 Johnson & Johnson Company Detail

11.10.2 Johnson & Johnson Business Overview

11.10.3 Johnson & Johnson Diabetes Therapy and Drug Delivery Introduction

11.10.4 Johnson & Johnson Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.10.5 Johnson & Johnson Recent Development

11.11 Synertech

11.11.1 Synertech Company Detail

11.11.2 Synertech Business Overview

11.11.3 Synertech Diabetes Therapy and Drug Delivery Introduction

11.11.4 Synertech Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.11.5 Synertech Recent Development

11.12 Zosano Pharma

11.12.1 Zosano Pharma Company Detail

11.12.2 Zosano Pharma Business Overview

11.12.3 Zosano Pharma Diabetes Therapy and Drug Delivery Introduction

11.12.4 Zosano Pharma Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.12.5 Zosano Pharma Recent Development

11.13 Relmada Therapeutics

11.13.1 Relmada Therapeutics Company Detail

11.13.2 Relmada Therapeutics Business Overview

11.13.3 Relmada Therapeutics Diabetes Therapy and Drug Delivery Introduction

11.13.4 Relmada Therapeutics Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.13.5 Relmada Therapeutics Recent Development

11.14 Eli Lilly

11.14.1 Eli Lilly Company Detail

11.14.2 Eli Lilly Business Overview

11.14.3 Eli Lilly Diabetes Therapy and Drug Delivery Introduction

11.14.4 Eli Lilly Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.14.5 Eli Lilly Recent Development

11.15 Transdermal Specialties

11.15.1 Transdermal Specialties Company Detail

11.15.2 Transdermal Specialties Business Overview

11.15.3 Transdermal Specialties Diabetes Therapy and Drug Delivery Introduction

11.15.4 Transdermal Specialties Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023)

11.15.5 Transdermal Specialties Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Inhalable Insulin

    Table 3. Key Players of Oral Insulin

    Table 4. Key Players of Insulin Patches

    Table 5. Key Players of CGM Systems

    Table 6. Key Players of Artificial Pancreas

    Table 7. Global Diabetes Therapy and Drug Delivery Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Diabetes Therapy and Drug Delivery Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Diabetes Therapy and Drug Delivery Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Diabetes Therapy and Drug Delivery Market Share by Region (2018-2023)

    Table 11. Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Diabetes Therapy and Drug Delivery Market Share by Region (2024-2029)

    Table 13. Diabetes Therapy and Drug Delivery Market Trends

    Table 14. Diabetes Therapy and Drug Delivery Market Drivers

    Table 15. Diabetes Therapy and Drug Delivery Market Challenges

    Table 16. Diabetes Therapy and Drug Delivery Market Restraints

    Table 17. Global Diabetes Therapy and Drug Delivery Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Diabetes Therapy and Drug Delivery Market Share by Players (2018-2023)

    Table 19. Global Top Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Therapy and Drug Delivery as of 2022)

    Table 20. Ranking of Global Top Diabetes Therapy and Drug Delivery Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Diabetes Therapy and Drug Delivery Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Diabetes Therapy and Drug Delivery Product Solution and Service

    Table 24. Date of Enter into Diabetes Therapy and Drug Delivery Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Diabetes Therapy and Drug Delivery Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2018-2023)

    Table 28. Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2024-2029)

    Table 30. Global Diabetes Therapy and Drug Delivery Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2018-2023)

    Table 32. Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2024-2029)

    Table 34. North America Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Diabetes Therapy and Drug Delivery Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Diabetes Therapy and Drug Delivery Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Diabetes Therapy and Drug Delivery Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Diabetes Therapy and Drug Delivery Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Diabetes Therapy and Drug Delivery Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Diabetes Therapy and Drug Delivery Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Abbott Laboratories Company Detail

    Table 50. Abbott Laboratories Business Overview

    Table 51. Abbott Laboratories Diabetes Therapy and Drug Delivery Product

    Table 52. Abbott Laboratories Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 53. Abbott Laboratories Recent Development

    Table 54. Medtronic Company Detail

    Table 55. Medtronic Business Overview

    Table 56. Medtronic Diabetes Therapy and Drug Delivery Product

    Table 57. Medtronic Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 58. Medtronic Recent Development

    Table 59. Sanofi Company Detail

    Table 60. Sanofi Business Overview

    Table 61. Sanofi Diabetes Therapy and Drug Delivery Product

    Table 62. Sanofi Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 63. Sanofi Recent Development

    Table 64. Novo Nordisk Company Detail

    Table 65. Novo Nordisk Business Overview

    Table 66. Novo Nordisk Diabetes Therapy and Drug Delivery Product

    Table 67. Novo Nordisk Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 68. Novo Nordisk Recent Development

    Table 69. MannKind Company Detail

    Table 70. MannKind Business Overview

    Table 71. MannKind Diabetes Therapy and Drug Delivery Product

    Table 72. MannKind Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 73. MannKind Recent Development

    Table 74. Enteris BioPharma Company Detail

    Table 75. Enteris BioPharma Business Overview

    Table 76. Enteris BioPharma Diabetes Therapy and Drug Delivery Product

    Table 77. Enteris BioPharma Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 78. Enteris BioPharma Recent Development

    Table 79. Dexcom Company Detail

    Table 80. Dexcom Business Overview

    Table 81. Dexcom Diabetes Therapy and Drug Delivery Product

    Table 82. Dexcom Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 83. Dexcom Recent Development

    Table 84. Senseonics Holding Company Detail

    Table 85. Senseonics Holding Business Overview

    Table 86. Senseonics Holding Diabetes Therapy and Drug Delivery Product

    Table 87. Senseonics Holding Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 88. Senseonics Holding Recent Development

    Table 89. Medtech Company Detail

    Table 90. Medtech Business Overview

    Table 91. Medtech Diabetes Therapy and Drug Delivery Product

    Table 92. Medtech Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 93. Medtech Recent Development

    Table 94. Johnson & Johnson Company Detail

    Table 95. Johnson & Johnson Business Overview

    Table 96. Johnson & Johnson Diabetes Therapy and Drug Delivery Product

    Table 97. Johnson & Johnson Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 98. Johnson & Johnson Recent Development

    Table 99. Synertech Company Detail

    Table 100. Synertech Business Overview

    Table 101. Synertech Diabetes Therapy and Drug Delivery Product

    Table 102. Synertech Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 103. Synertech Recent Development

    Table 104. Zosano Pharma Company Detail

    Table 105. Zosano Pharma Business Overview

    Table 106. Zosano Pharma Diabetes Therapy and Drug Delivery Product

    Table 107. Zosano Pharma Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 108. Zosano Pharma Recent Development

    Table 109. Relmada Therapeutics Company Detail

    Table 110. Relmada Therapeutics Business Overview

    Table 111. Relmada Therapeutics Diabetes Therapy and Drug Delivery Product

    Table 112. Relmada Therapeutics Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 113. Relmada Therapeutics Recent Development

    Table 114. Eli Lilly Company Detail

    Table 115. Eli Lilly Business Overview

    Table 116. Eli Lilly Diabetes Therapy and Drug Delivery Product

    Table 117. Eli Lilly Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 118. Eli Lilly Recent Development

    Table 119. Transdermal Specialties Company Detail

    Table 120. Transdermal Specialties Business Overview

    Table 121. Transdermal Specialties Diabetes Therapy and Drug Delivery Product

    Table 122. Transdermal Specialties Revenue in Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)

    Table 123. Transdermal Specialties Recent Development

    Table 124. Research Programs/Design for This Report

    Table 125. Key Data Information from Secondary Sources

    Table 126. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Diabetes Therapy and Drug Delivery Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Diabetes Therapy and Drug Delivery Market Share by Type: 2022 VS 2029

    Figure 3. Inhalable Insulin Features

    Figure 4. Oral Insulin Features

    Figure 5. Insulin Patches Features

    Figure 6. CGM Systems Features

    Figure 7. Artificial Pancreas Features

    Figure 8. Global Diabetes Therapy and Drug Delivery Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Diabetes Therapy and Drug Delivery Market Share by Application: 2022 VS 2029

    Figure 10. Diagnostic/Clinics Case Studies

    Figure 11. ICUs Case Studies

    Figure 12. Home Healthcare Case Studies

    Figure 13. Diabetes Therapy and Drug Delivery Report Years Considered

    Figure 14. Global Diabetes Therapy and Drug Delivery Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Diabetes Therapy and Drug Delivery Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Diabetes Therapy and Drug Delivery Market Share by Region: 2022 VS 2029

    Figure 17. Global Diabetes Therapy and Drug Delivery Market Share by Players in 2022

    Figure 18. Global Top Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Therapy and Drug Delivery as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Diabetes Therapy and Drug Delivery Revenue in 2022

    Figure 20. North America Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Diabetes Therapy and Drug Delivery Market Share by Country (2018-2029)

    Figure 22. United States Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Diabetes Therapy and Drug Delivery Market Share by Country (2018-2029)

    Figure 26. Germany Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Diabetes Therapy and Drug Delivery Market Share by Region (2018-2029)

    Figure 34. China Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Diabetes Therapy and Drug Delivery Market Share by Country (2018-2029)

    Figure 42. Mexico Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Diabetes Therapy and Drug Delivery Market Share by Country (2018-2029)

    Figure 46. Turkey Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Abbott Laboratories Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 49. Medtronic Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 50. Sanofi Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 51. Novo Nordisk Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 52. MannKind Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 53. Enteris BioPharma Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 54. Dexcom Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 55. Senseonics Holding Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 56. Medtech Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 57. Johnson & Johnson Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 58. Synertech Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 59. Zosano Pharma Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 60. Relmada Therapeutics Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 61. Eli Lilly Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 62. Transdermal Specialties Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2018-2023)

    Figure 63. Bottom-up and Top-down Approaches for This Report

    Figure 64. Data Triangulation

    Figure 65. Key Executives Interviewed